2.A Case of Moyamoya Disease in a Girl with Thyrotoxicosis.
Ran LEE ; Kihye SUNG ; Yong Mean PARK ; Jeong Jin YU ; Young Cho KOH ; Sochung CHUNG
Yonsei Medical Journal 2009;50(4):594-598
Moyamoya disease is a cerebrovascular disorder of unknown cause, characterized by slowly progressive bilateral stenosis or occlusion of the internal carotid arteries and produces collateral vessels. Moyamoya syndrome has rarely been reported in association with Graves' disease, especially in children. Several reports suggest that a cerebral infarction might have occurred in patients with clinical and laboratory evidence of hyperthyroid function. We report a case of Moyamoya disease in a girl with Down syndrome and thyrotoxicosis, and we review the relevant literature. To our best knowledge, this is the first report of Moyamoya disease associated with thyrotoxicosis in a young person in Korea.
Down Syndrome/complications
;
Female
;
Humans
;
Korea
;
Moyamoya Disease/*complications/*diagnosis
;
Thyrotoxicosis/*complications
;
Young Adult
3.Moyamoya Syndrome Caused by Paroxysmal Nocturnal Hemoglobinuria.
Zhi-Juan CHENG ; Yao-Yao SHEN ; Ishak Mohamed WARSAME ; Ting-Min DAI ; Jiang-Long TU
Chinese Medical Journal 2018;131(23):2874-2876
Adult
;
Hemoglobinuria, Paroxysmal
;
complications
;
pathology
;
Humans
;
Male
;
Moyamoya Disease
;
diagnosis
;
etiology
;
pathology
;
Young Adult
4.The Rare Association of Moyamoya Disease and Cerebral Arteriovenous Malformations: a Case Report.
Te Chang WU ; Wan Yuo GUO ; Hsiu Mei WU ; Feng Chi CHANG ; Cheng Ying SHIAU ; Wen Yuh CHUNG
Korean Journal of Radiology 2008;9(Suppl):S65-S67
A 36-year-old man was diagnosed with a right temporal lobe grade II cerebral arteriovenous malformation (cAVM) and was treated with radiosurgery. At nine months after the cAVM radiosurgery, the patient began to develop bilateral focal narrowing at the M1 segments of the bilateral middle cerebral arteries. The narrowing progressively deteriorated as was demonstrated on longitudinal serial follow-up MR imaging. X-ray angiography performed at 51 months after radiosurgery confirmed that the cAVM was cured and a diagnosis of moyamoya disease. To the best of our knowledge, this is the first case of cAVM-associated moyamoya disease that developed after radiosurgery. Given the chronological sequence of disease development and radiation dose distribution of radiosurgery, it is proposed that humoral or unknown predisposing factors, rather than direct radiation effects, are the cause of moyamoya disease associated with cAVM.
Adult
;
Humans
;
Intracranial Arteriovenous Malformations/diagnosis/*surgery
;
Magnetic Resonance Imaging
;
Male
;
Moyamoya Disease/*etiology
;
Postoperative Complications
;
Radiosurgery
5.Systemic Lupus Erythematosus Associated with Familial Moyamoya Disease.
Chang Min LEE ; Sang Yeob LEE ; Seung Hoon RYU ; Sung Won LEE ; Kyung Won PARK ; Won Tae CHUNG
The Korean Journal of Internal Medicine 2003;18(4):244-247
We report on a 13-year-old female with systemic lupus erythematosus (SLE) who exhibited symptoms of severe migraine and familial moyamoya disease. Cerebral magnetic resonance angiography (MRA) showed stenosis and occlusion of the bilateral internal carotid arteries associated with the development of collateral circulation (moyamoya vessels). In a child, as in this case, headaches with cerebral infarction associated with moyamoya disease are unusual. Few cases of SLE associated with familial moyamoya disease have been reported, with no previous reports of such cases from Korea. There were no evidences of antiphospholipid syndrome, and activity of SLE or other risk factors for cerebral occlusion were also absent.
Adolescent
;
Carotid Artery, Internal/pathology
;
Female
;
Human
;
Lupus Erythematosus, Systemic/*complications
;
Magnetic Resonance Angiography
;
Migraine/etiology
;
Moyamoya Disease/*diagnosis/*genetics
6.Percutaneous left atrial appendage occlusion therapy in a female recurrent ischemic stroke patient with persistent atrial fibrillation and moyamoya disease.
Song ZUO ; Jia Hui WU ; Xiao Wen BO ; Xin ZHAO ; Xu LI ; Song Nan LI ; Jian Zeng DONG ; Chang Sheng MA
Chinese Journal of Cardiology 2020;48(11):982-984
7.Fatal ischemic stroke in a case of progressive moyamoya vasculopathy associated with uncontrolled thyrotoxicosis.
Bon D KU ; Key Chung PARK ; Sung Sang YOON
The Korean Journal of Internal Medicine 2015;30(4):543-546
No abstract available.
Adult
;
Brain Ischemia/diagnosis/*etiology
;
Cerebral Angiography
;
Fatal Outcome
;
Female
;
Humans
;
Hyperventilation/complications
;
Moyamoya Disease/*complications/diagnosis/therapy
;
Risk Factors
;
Stroke/diagnosis/*etiology
;
Thyroid Crisis/*complications/diagnosis/therapy
8.Off-Pump Coronary Artery Bypass Grafting in Moyamoya Disease.
Yonsei Medical Journal 2007;48(5):876-878
Moyamoya disease is an occlusive intracranial arteriopathy owing to intimal hyperplasia with formation of abnormal cerebrovascular collateral networks; however, the etiology remains unclear. Although this disease is known to be associated with renovascular hypertension, it is extremely rare for it to be associated with stenoses of the coronary arteries. We herein described a case of a 56-year-old female with angina and asymptomatic moyamoya disease. We performed off-pump coronary artery bypass grafting (OPCAB) to avoid cardiopulmonary bypass and the risk of intraoperative hypotension. Conventional coronary artery bypass grafting has a potential risk of brain ischemia in moyamoya patients, but OPCAB may avoid this perioperative cerebral ischemic complication.
*Coronary Artery Bypass, Off-Pump/adverse effects
;
Coronary Stenosis/complications/surgery
;
Female
;
Humans
;
Intraoperative Complications/prevention & control
;
Middle Aged
;
Moyamoya Disease/complications/*surgery
;
Risk Factors
10.Clinical analysis of 15 pregnant women complicated with moyamoya disease.
Yu Xiang YANG ; Wei Na GAO ; Chen CHEN ; Xian Lan ZHAO
Chinese Journal of Obstetrics and Gynecology 2023;58(4):270-276
Objective: To explore the effects of pregnancy complicated with moyamoya disease on maternal and fetal outcomes. Methods: The general clinical data and maternal and fetal outcomes of 20 pregnancies of 15 patients with moyamoya disease admitted to the First Affiliated Hospital of Zhengzhou University from January 2012 to October 2022 were retrospectively analyzed. Results: (1) General information: among the 20 pregnancies of 15 clearly diagnosed pregnant women complicated with moyamoya disease, 12 were diagnosed before pregnancy (60%, 12/20), 3 were diagnosed during pregnancy (15%, 3/20), and 5 were diagnosed during puerperal period (25%, 5/20). There were 7 cases of primipara (35%, 7/20) and 13 cases of multipara (65%, 13/20). (2) Pregnancy complications and maternal and infant outcomes: among the 20 pregnancies of 15 pregnant women with moyamoya disease, there were 9 pregnancy complications (45%, 9/20), including 5 gestational hypertension (25%, 5/20), 2 severe pre-eclampsia (10%, 2/20), 1 hyperlipidemia and 1 gestational diabetes mellitus (5%, 1/20). There were 2 case of drug abortion in the first trimester, 3 cases of labor induction in the second trimester, and 15 cases of delivery during the third trimester. All the 15 deliveries were cesarean section, of which 11 (11/15) were cesarean sections with medical indications, and 4 (4/15) were cesarean sections caused by personal factors. General anesthesia was used in 5 cases (5/15), epidural block anesthesia in 7 cases (7/15), and combined spinal and epidural anesthesia in 3 cases (3/15). The median gestational age of 15 neonates was 37.2 weeks (34.0 to 40.8 weeks), with 10 cases (10/15) were full-term infants, and 5 (5/15) were preterm infants (3 of which were associated with hypertensive disorder complicating pregnancy). The birth weight of 15 neonates was (2 853±454) g. Four neonates were admitted to neonatal intensive care unit (NICU), of which 3 cases were admitted to NICU due to premature delivery and 1 case was admitted to NICU due to neonatal jaundice. There was no neonatal asphyxia or death. All neonates were followed up from 4 months to 6 years after birth, and all grew well. (3) Neurological symptoms during pregnancy: 8 cases (40%, 8/20) had neurological symptoms during pregnancy, and 6 cases (30%, 6/20) had hemorrhagic symptoms, of which 3 cases occurred during the puerperal period (3/6). There were 2 cases of ischemic symptoms (10%, 2/20), all of which occurred during the puerperal period (2/2). (4) Analysis of factors related to the occurrence of cerebral hemorrhage: the incidence of cerebral hemorrhage in patients with moyamoya disease diagnosed before pregnancy was significantly lower than that in those without a clear diagnosis, and the incidence of cerebral hemorrhage in women with moyamoya disease was lower than that in primipara (all P<0.01). The incidence of cerebral hemorrhage in moyamoya patients without hypertensive disorder complicating pregrancy was lower than that in patients with hypertensive disorder complicating pregrancy, but the difference was not statistically significant (P>0.05). Conclusions: Pregnancy combined with moyamoya disease has adverse effects on maternal and infant outcomes, and the incidence of pregnancy complications increases. Cerebral hemorrhage occurres in prenatal and puperium, while cerebral ischemia occurres mainly in puperium.
Infant
;
Pregnancy
;
Infant, Newborn
;
Female
;
Humans
;
Pregnancy Outcome
;
Cesarean Section
;
Pregnant Women
;
Infant, Premature
;
Moyamoya Disease/complications*
;
Retrospective Studies
;
Pregnancy Complications/epidemiology*
;
Cerebral Hemorrhage